Literature DB >> 22432064

Molecular mechanisms influencing NK cell development: implications for NK cell malignancies.

Sally A Mujaj, Michelle M Spanevello, Maher K Gandhi, Jamie P Nourse.   

Abstract

Natural Killer (NK) cells are important effector cells in both the innate and adaptive immune responses. Although they were identified almost 40 years ago, our understanding of how and where NK cells develop is rudimentary. In particular, we have only a limited understanding of the signaling pathways that need to be activated to cause NK cell commitment and maturation. Knowledge of this process is important as disruptions can lead to the development of highly aggressive NK cell malignancies. In this review, we discuss the known molecular mechanisms that trigger NK cell commitment, prompt them to mature and finally allow them to become functional killers. Known disruptions in this developmental process, and how they may contribute to malignancy, are also addressed.

Entities:  

Keywords:  Animal; Natural Killer cell; cell differentiation; cytokines; gene expression regulation; human; lymphoma; lymphopoiesis; transcription factors

Year:  2011        PMID: 22432064      PMCID: PMC3301417     

Source DB:  PubMed          Journal:  Am J Blood Res        ISSN: 2160-1992


  61 in total

1.  The ETS protein MEF plays a critical role in perforin gene expression and the development of natural killer and NK-T cells.

Authors:  H Daniel Lacorazza; Yasushi Miyazaki; Antonio Di Cristofano; Anthony Deblasio; Cyrus Hedvat; Jin Zhang; Carlos Cordon-Cardo; Shifeng Mao; Pier Paolo Pandolfi; Stephen D Nimer
Journal:  Immunity       Date:  2002-10       Impact factor: 31.745

Review 2.  NK cells at the interface between innate and adaptive immunity.

Authors:  A Moretta; E Marcenaro; S Parolini; G Ferlazzo; L Moretta
Journal:  Cell Death Differ       Date:  2007-06-01       Impact factor: 15.828

Review 3.  Extrinsic and intrinsic regulation of early natural killer cell development.

Authors:  Markus D Boos; Kevin Ramirez; Barbara L Kee
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

4.  Roles for common cytokine receptor gamma-chain-dependent cytokines in the generation, differentiation, and maturation of NK cell precursors and peripheral NK cells in vivo.

Authors:  Christian A J Vosshenrich; Thomas Ranson; Sandrine I Samson; Erwan Corcuff; Francesco Colucci; Eleftheria E Rosmaraki; James P Di Santo
Journal:  J Immunol       Date:  2005-02-01       Impact factor: 5.422

5.  A role for Blimp1 in the transcriptional network controlling natural killer cell maturation.

Authors:  Axel Kallies; Sebastian Carotta; Nicholas D Huntington; Nicholas J Bernard; David M Tarlinton; Mark J Smyth; Stephen L Nutt
Journal:  Blood       Date:  2010-12-03       Impact factor: 22.113

6.  Amplification and specific expression of T-bet gene in nasal NK/T-cell lymphoma.

Authors:  Y Ye; T Li; B Zhang; Z Guo
Journal:  Leuk Lymphoma       Date:  2007-01

Review 7.  Progress in understanding and managing natural killer-cell malignancies.

Authors:  Kazuo Oshimi
Journal:  Br J Haematol       Date:  2007-10-03       Impact factor: 6.998

8.  Extranodal natural-killer/t-cell lymphoma, nasal type.

Authors:  Harinder Gill; Raymond H S Liang; Eric Tse
Journal:  Adv Hematol       Date:  2010-12-30

9.  Interleukin 2 receptor signaling regulates the perforin gene through signal transducer and activator of transcription (Stat)5 activation of two enhancers.

Authors:  J Zhang; I Scordi; M J Smyth; M G Lichtenheld
Journal:  J Exp Med       Date:  1999-11-01       Impact factor: 14.307

Review 10.  Cellular responses to viral infection in humans: lessons from Epstein-Barr virus.

Authors:  Andrew D Hislop; Graham S Taylor; Delphine Sauce; Alan B Rickinson
Journal:  Annu Rev Immunol       Date:  2007       Impact factor: 28.527

View more
  1 in total

1.  NK Cells as Possible Prognostic Factor in Childhood Acute Lymphoblastic Leukemia.

Authors:  Agnieszka Mizia-Malarz; Grażyna Sobol-Milejska
Journal:  Dis Markers       Date:  2019-01-02       Impact factor: 3.434

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.